First Eagle Investment Management

First Eagle Investment Management’s X4 Pharmaceuticals XFOR Stock Holding History

First Eagle Investment Management’s Portfolio XFOR Stock Details XFOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,191	Closed	-$536K	–	149
2019 Q2	$536K	Buy	1,191 +500	+72%	+$254K	﹤0.01%	144
2019 Q1	$361K	Hold	691	–	–	﹤0.01%	150
2018 Q4	$289K	Hold	691	–	–	﹤0.01%	160
2018 Q3	$201K	Hold	691	–	–	﹤0.01%	168
2018 Q2	$452K	Hold	691	–	–	﹤0.01%	164
2018 Q1	$2.85M	Buy	+691	New	+$2.01M	0.01%	151

Other funds holding XFOR

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cormorant Asset Management Boston, Massachusetts $1.98B AUM 737.95% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return